Literature DB >> 27894201

Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Marta Pinto-Grau1,2, Tom Burke1,2, Katie Lonergan1,2, Caroline McHugh3, Iain Mays1, Caoifa Madden1, Alice Vajda1, Mark Heverin1, Marwa Elamin1, Orla Hardiman1, Niall Pender1,2.   

Abstract

BACKGROUND: Cognitive and behavioural changes are an important aspect in Amyotrophic Lateral Sclerosis (ALS). The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) briefly assesses these changes in ALS.
OBJECTIVE: To validate the ECAS against a standardised neuropsychological battery and assess its sensitivity and specificity using age and education adjusted cut-off scores.
METHOD: 30 incident ALS cases were assessed on both, ECAS and neuropsychological battery. Age and education adjusted cut-off scores were created from a sample of 82 healthy controls.
RESULTS: ECAS composite scores (Total, ALS Specific and Non-Specific) were highly correlated with battery composite scores. High correlations were also observed between ECAS and full battery cognitive domains and subtests. The ECAS Total, ALS Specific and Non-Specific scores were highly sensitive to cognitive impairment. ECAS ALS-Specific cognitive domains also evidenced high sensitivity. Individual subtest sensitivity was medium to low, suggesting that caution should be used when interpreting these scores. Low positive predictive values indicated the presence of false positives.
CONCLUSIONS: Psychometric properties of the ECAS using age and education adjusted norms indicate that the ECAS, when used as an overall measure of cognitive decline, is highly sensitive. Further comprehensive assessment is required for patients that present as impaired on the ECAS.

Entities:  

Keywords:  ALS; Cognition; ECAS; screen; standardisation; validation

Mesh:

Year:  2016        PMID: 27894201     DOI: 10.1080/21678421.2016.1249887

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  19 in total

1.  Extra-motor cerebral changes and manifestations in primary lateral sclerosis.

Authors:  Eoin Finegan; Stacey Li Hi Shing; Rangariroyashe H Chipika; Kai Ming Chang; Mary Clare McKenna; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Niall Pender; Colette Donaghy; Siobhan Hutchinson; Russell L McLaughlin; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-07       Impact factor: 3.978

2.  Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival.

Authors:  Tom Burke; Miriam Galvin; Marta Pinto-Grau; Katie Lonergan; Caoifa Madden; Iain Mays; Sile Carney; Orla Hardiman; Niall Pender
Journal:  J Neurol       Date:  2017-03-09       Impact factor: 4.849

3.  Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.

Authors:  Margaret O'Brien; Tom Burke; Mark Heverin; Alice Vajda; Russell McLaughlin; John Gibbons; Susan Byrne; Marta Pinto-Grau; Marwa Elamin; Niall Pender; Orla Hardiman
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

4.  Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

Authors:  Corey T McMillan; Joanne Wuu; Katya Rascovsky; Stephanie Cosentino; Murray Grossman; Lauren Elman; Colin Quinn; Luis Rosario; Jessica H Stark; Volkan Granit; Hannah Briemberg; Sneha Chenji; Annie Dionne; Angela Genge; Wendy Johnston; Lawrence Korngut; Christen Shoesmith; Lorne Zinman; Sanjay Kalra; Michael Benatar
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-03-07       Impact factor: 3.528

5.  Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Authors:  Christopher Crockford; Judith Newton; Katie Lonergan; Caoifa Madden; Iain Mays; Meabhdh O'Sullivan; Emmet Costello; Marta Pinto-Grau; Alice Vajda; Mark Heverin; Niall Pender; Ammar Al-Chalabi; Orla Hardiman; Sharon Abrahams
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-07       Impact factor: 4.092

6.  Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.

Authors:  Tom Burke; Orla Hardiman; Marta Pinto-Grau; Katie Lonergan; Mark Heverin; Katy Tobin; Anthony Staines; Miriam Galvin; Niall Pender
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

7.  Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).

Authors:  Sneha Chenji; Abdullah Ishaque; Dennell Mah; Esther Fujiwara; Christian Beaulieu; Peter Seres; Simon J Graham; Richard Frayne; Lorne Zinman; Angela Genge; Lawrence Korngut; Wendy Johnston; Sanjay Kalra
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

8.  Localization of Brain Networks Engaged by the Sustained Attention to Response Task Provides Quantitative Markers of Executive Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Roisin McMackin; Stefan Dukic; Emmet Costello; Marta Pinto-Grau; Antonio Fasano; Teresa Buxo; Mark Heverin; Richard Reilly; Muthuraman Muthuraman; Niall Pender; Orla Hardiman; Bahman Nasseroleslami
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

9.  The clinical and radiological profile of primary lateral sclerosis: a population-based study.

Authors:  Eoin Finegan; Rangariroyashe H Chipika; Stacey Li Hi Shing; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Colette Donaghy; Russell L McLaughlin; Niall Pender; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2019-07-19       Impact factor: 4.849

10.  Mismatch Negativity as an Indicator of Cognitive Sub-Domain Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Parameswaran Mahadeva Iyer; Kieran Mohr; Michael Broderick; Brighid Gavin; Tom Burke; Peter Bede; Marta Pinto-Grau; Niall P Pender; Russell McLaughlin; Alice Vajda; Mark Heverin; Edmund C Lalor; Orla Hardiman; Bahman Nasseroleslami
Journal:  Front Neurol       Date:  2017-08-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.